Viral exposure signature predicts hepatocellular carcinoma

(HealthDay)—A viral exposure signature can predict hepatocellular carcinoma (HCC) risk before clinical diagnosis among at-risk patients, according to a study published online June 10 in Cell. Jinping Liu, Ph.D., of the National Cancer Institute in Bethesda, Maryland, and colleagues used a synthetic human virome technology, VirScan, to perform serological profiling of viral infection history in 899 individuals from a case-control […]

Read more

Universal gut microbiome-derived signature predicts cirrhosis

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease worldwide, affecting an estimated one-quarter of the global population. It is a progressive condition that, in worst cases, can lead to cirrhosis, liver cancer, liver failure and death. In a new paper published online June 30, 2020 in Cell Metabolism, a team of scientists, led by researchers […]

Read more